LEF1-AS1-202 displayed significantly decreased levels in MPS patients compared to those without MPSs (Figure 1A) but not in patients affected by persistent MNSs compared to their controls (Figure S2A). This evidence concerns the gene LEF1 and mucopolysaccharidosis.